N-acetyl-9-O-acetylneuraminic acid

Metabolite details

Identifier

NYWZBRWKDRMPAS-GRRZBWEESA-N

InChI Key

NYWZBRWKDRMPAS-GRRZBWEESA-N

IUPAC name

5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid

Preferred name

N-acetyl-9-O-acetylneuraminic acid

INN name

—

Synonym

9-O-Acetylsialic acid

ChEBI

CHEBI:21500

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Comparative Metabolomic Profiling of Compatible and Incompatible Interactions Between Potato and Phytophthora infestans
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G1_PBS_vs_G2_DSS
• Ziyun_No.1_0h_vs_Ziyun_No.1_96h
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d
• Control_vs_BP3_Low_Concentration